Author

Roman L

unsw sydney - Cited by 1,765

Biography

He is affiliated to Paediatric Unit, Hospital del Mar, Barcelona, Spain. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals
Title
Cited by
Year
The 2020 international alliance for the control of scabies consensus criteria for the diagnosis of scabies
D Engelman, J Yoshizumi, RJ Hay, M Osti, G Micali, S Norton, S Walton, ...British Journal of Dermatology 183 (5), 808-820, 2020202
157
2020
The public health control of scabies: priorities for research and action
D Engelman, PT Cantey, M Marks, AW Solomon, AY Chang, O Chosidow, ...The Lancet 394 (10192), 81-92, 2019201
118
2019
The prevalence of scabies and impetigo in the Solomon Islands: a population-based survey
DS Mason, M Marks, O Sokana, AW Solomon, DC Mabey, L Romani, ...PLoS neglected tropical diseases 10 (6), e0004803, 2016201
93
2016
Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial
L Romani, M Marks, O Sokana, T Nasi, B Kamoriki, B Cordell, H Wand, ...The Lancet Infectious Diseases 19 (5), 510-518, 2019201
77
2019
The epidemiology of scabies and impetigo in relation to demographic and residential characteristics: baseline findings from the skin health intervention Fiji trial
L Romani, MJ Whitfeld, J Koroivueta, M Kama, H Wand, L Tikoduadua, ...The American journal of tropical medicine and hygiene 97 (3), 845, 2017201
55
2017
Randomized trial of community treatment with azithromycin and ivermectin mass drug administration for control of scabies and impetigo
M Marks, H Toloka, C Baker, C Kositz, J Asugeni, E Puiahi, R Asugeni, ...Clinical infectious diseases 68 (6), 927-933, 2019201
49
2019
Mass drug administration for scabies—2 years of follow-up
L Romani, MJ Whitfeld, J Koroivueta, M Kama, H Wand, L Tikoduadua, ...New England Journal of Medicine 381 (2), 186-187, 2019201
42
2019
Prevalence of scabies and impetigo 3 years after mass drug administration with ivermectin and azithromycin
M Marks, L Romani, O Sokana, L Neko, R Harrington, T Nasi, H Wand, ...Clinical Infectious Diseases 70 (8), 1591-1595, 2020202
35
2020
A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current …
P Jittamala, W Monteiro, MR Smit, B Pedrique, S Specht, CJ Chaccour, ...PLoS neglected tropical diseases 15 (3), e0009144, 2021202
30
2021
Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial
L Romani, M Marks, O Sokana, T Nasi, B Kamoriki, H Wand, MJ Whitfeld, ...The Lancet Global Health 6 (10), e1132-e1138, 2018201
28
2018
Exploration of a simplified clinical examination for scabies to support public health decision-making
M Marks, D Engelman, L Romani, D Mason, O Sokana, M Kama, ...PLoS neglected tropical diseases 12 (12), e0006996, 2018201
24
2018
Community perspectives on scabies, impetigo and mass drug administration in Fiji: a qualitative study
E Mitchell, S Bell, LJ Thean, A Sahukhan, M Kama, A Koroivueti, J Kaldor, ...PLoS neglected tropical diseases 14 (12), e0008825,
20
2020
A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination
MJ Lydeamore, PT Campbell, DG Regan, SYC Tong, RM Andrews, ...Mathematical biosciences 309, 163-173, 202
19
2019
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster …
M Hardy, J Samuela, M Kama, M Tuicakau, L Romani, MJ Whitfeld, ...PLoS neglected tropical diseases 14 (3), e0008106, 2020202
18
2020
Recent advances in understanding and treating scabies
E Welch, L Romani, MJ WhitfeldFaculty Reviews 10, 2021202
17
2021
Defining the need for public health control of scabies in Solomon Islands
SJ Lake, D Engelman, O Sokana, T Nasi, D Boara, AC Grobler, MH Osti, ...PLoS neglected tropical diseases 15 (2), e0009142, 2021202
12
2021
Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)
SJ Lake, SL Phelan, D Engelman, O Sokana, T Nasi, D Boara, C Gorae, ...BMJ open (8), e037305, 2020202
10
2020
Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children
M Marks, S Gwyn, H Toloka, C Kositz, J Asugeni, R Asugeni, J Diau, ...Clinical Infectious Diseases 71 (12), 3226-3228, 2020202
9
2020
Health-related quality of life impact of scabies in the Solomon Islands
SJ Lake, D Engelman, O Sokana, T Nasi, D Boara, M Marks, MJ Whitfeld, ...Transactions of The Royal Society of Tropical Medicine and Hygiene 116 (2 …, 2022202
8
2022
Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018–2020
Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 201–2020LJ Thean, L Romani, D Engelman, H Wand, A Jenney, J Mani, J Paka, ...The Lancet Regional Health–Western Pacific 22, 2022202
8
2022

Referred From: https://scholar.google.com/citations?user=g3SOZoYAAAAJ&hl=en

Cited by
Citations 1765
h-index 18
i10-index 22
Recommended Journals
Open Access Journals